Literature DB >> 15799066

Starter sequence for steady-state free precession imaging.

D L Foxall1.   

Abstract

The dynamic equilibrium exploited by balanced steady-state free precession imaging develops slowly because its formation is dependent on both spin-spin and spin-lattice relaxation times. Attempting to image before steady state is established results in artifacts due to transient signal oscillations. Using a starter sequence to precondition the spin system can significantly reduce the delay before imaging. An improved design for a steady-state starter sequence is presented. The new sequence has the advantage of uniformly exciting the steady-state response for all resonance offsets and can be phase cycled to suppress banding artifacts. Copyright 2005 Wiley-Liss, Inc.

Mesh:

Year:  2005        PMID: 15799066     DOI: 10.1002/mrm.20437

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  Noncontrast SSFP pulmonary vein magnetic resonance angiography: impact of off-resonance and flow.

Authors:  Peng Hu; Christian T Stoeck; Jouke Smink; Dana C Peters; Long Ngo; Beth Goddu; Kraig V Kissinger; Lois A Goepfert; Jonathan Chan; Thomas H Hauser; Neil M Rofsky; Warren J Manning; Reza Nezafat
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

2.  Whole-heart coronary magnetic resonance angiography at 3.0T using short-TR steady-state free precession, vastly undersampled isotropic projection reconstruction.

Authors:  Jingsi Xie; Peng Lai; Himanshu Bhat; Debiao Li
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

3.  Selection of magnetization catalyzation and readout methods for modified Look-Locker inversion recovery: a T1 mapping primer.

Authors:  Donnie Cameron; David M Higgins; Christian Stehning; Marc Kouwenhoven; Mustapha Bouhrara; Michael P Frenneaux; Dana K Dawson; Thomas W Redpath
Journal:  Magn Reson Imaging       Date:  2015-02-07       Impact factor: 3.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.